Drug Profile
Research programme: PPAR alpha agonists - CrystalGenomics
Alternative Names: PPAR alpha agonists - CrystalGenomicsLatest Information Update: 07 Feb 2011
Price :
$50
*
At a glance
- Originator CrystalGenomics
- Class
- Mechanism of Action Peroxisome proliferator-activated receptor alpha agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Obesity